OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001502152

GlobeStar Therapeutics Corp

GlobeStar Therapeutics Corp (CIK 0001502152, EIN 27-3480481) reported revenue of $77 for FY2020 (2019-10-01 to 2020-09-30) and net income of -$1.95 million (-$1,949,249) for FY2023 (2022-10-01 to 2023-09-30), as filed in its 10-K filed 2022-01-05 (accession 0001161697-22-000027) and its 10-K filed 2024-01-19 (accession 0001161697-24-000049).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends September 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001502152
EIN27-3480481
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationWY
Fiscal year endSeptember 30
Filer category<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_1p9z8tvtjeqxyebg4ykyaw2m2y
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$77FY20202019-10-01 to 2020-09-3010-K2022-01-050001161697-22-000027Revenues
Net income-$1,949,249FY20232022-10-01 to 2023-09-3010-K2024-01-190001161697-24-000049NetIncomeLoss
Total assets$9,915FY2022as of 2022-09-3010-K2024-01-190001161697-24-000049Assets
Total liabilities$1,433,861FY2023as of 2023-09-3010-K2024-01-190001161697-24-000049Liabilities
Stockholders' equity-$1,433,861FY2023as of 2023-09-3010-K2024-01-190001161697-24-000049StockholdersEquity
Operating cash flow-$205,760FY20232022-10-01 to 2023-09-3010-K2024-01-190001161697-24-000049NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.02 per shareFY20212020-10-01 to 2021-09-3010-K2022-01-050001161697-22-000027EarningsPerShareBasicAndDiluted
Shares outstanding1,026,417,320 sharesFY2023as of 2024-01-1610-K2024-01-190001161697-24-000049EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2014-2023, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20202019-10-01 to 2020-09-30$7710-K2022-01-050001161697-22-000027
RevenueFY20192018-10-01 to 2019-09-30$42510-K2020-12-030001161697-20-000517
RevenueFY20182017-10-01 to 2018-09-30$89010-K2019-12-310001185185-19-001771
RevenueFY20172016-10-01 to 2017-09-30$010-K2019-01-030001185185-19-000011
RevenueFY20142013-10-01 to 2014-09-30$97,25210-K2015-01-270001161697-15-000043
Net incomeFY20232022-10-01 to 2023-09-30-$1,949,24910-K2024-01-190001161697-24-000049
Net incomeFY20222021-10-01 to 2022-09-30-$1,487,81010-K2024-01-190001161697-24-000049
Net incomeFY20212020-10-01 to 2021-09-30-$9,801,62810-K2023-01-090001161697-23-000049
Net incomeFY20202019-10-01 to 2020-09-30-$541,73110-K2022-01-050001161697-22-000027
Net incomeFY20192018-10-01 to 2019-09-30-$675,07210-K2020-12-030001161697-20-000517
Net incomeFY20182017-10-01 to 2018-09-30-$816,74110-K2019-12-310001185185-19-001771
Net incomeFY20172016-10-01 to 2017-09-30-$1,679,78910-K2019-01-030001185185-19-000011
Net incomeFY20152014-10-01 to 2015-09-30-$1,085,66210-K2016-01-220001161697-16-000635
Net incomeFY20142013-10-01 to 2014-09-30-$1,245,17010-K2016-01-220001161697-16-000635

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2024-10-112024-06-300001161697-24-000420form_10-q.htm
10-Q2024-06-282024-03-310001161697-24-000285form_10-q.htm
10-Q2024-03-122023-12-310001161697-24-000130form_10-q.htm
10-K2024-01-192023-09-300001161697-24-000049form_10-k.htm
10-Q2023-08-172023-06-300001161697-23-000456form_10-q.htm
10-Q2023-05-312023-03-310001161697-23-000332form_10-q.htm
10-Q2023-02-132022-12-310001161697-23-000103form_10-q.htm
10-K2023-01-092022-09-300001161697-23-000049form_10-k.htm
10-Q/A2022-08-232022-06-300001161697-22-000411form_10-q.htm
10-Q2022-08-222022-06-300001161697-22-000407form_10-q.htm
10-Q2022-06-012022-03-310001161697-22-000282form_10-q.htm
10-Q2022-02-142021-12-310001161697-22-000096form_10-q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001502152published by the sourcedata.sec.gov/submissions/CIK0001502152.json2026-10-21
Employer Identification Number (EIN) · US-EIN27-3480481published by the sourcedata.sec.gov/submissions/CIK0001502152.json2026-10-21

Former names

NameFromTo
AngioSoma, Inc.2016-06-222021-05-21
First Titan Corp.2010-11-032016-06-16

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001502152.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001502152.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001502152" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001502152/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001502152/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1502152"}

On SEC EDGAR

About this data